Rankings
▼
Calendar
ACAD Q2 2016 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
ACAD
ACADIA Pharmaceuticals Inc.
$4B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$97,000
Gross Profit
-$677,000
-697.9% margin
Operating Income
-$72M
-74147.4% margin
Net Income
-$71M
-73527.8% margin
EPS (Diluted)
$-0.63
QoQ Revenue Growth
+2325.0%
Cash Flow
Operating Cash Flow
-$57M
Free Cash Flow
-$65M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$438M
Total Liabilities
$29M
Stockholders' Equity
$409M
Cash & Equivalents
$132M
← FY 2016
All Quarters
Q3 2016 →
